A phase I/II study of Radiotherapy, Irinotecan, Capecitabine then Excision for locally advanced rectal cancer.
Phase of Trial: Phase I/II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Capecitabine; Irinotecan
- Indications Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms RICE
- 25 Jul 2011 Additional lead trial center identified as reported by UKCRN.
- 06 May 2010 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 06 May 2010 New source identified and integrated (ISRCTN: Current Controlled Trials record no. 59158409).